Clinical Trial Update: Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L. [NA]

View source ↗

Summary

The update reports on the interpretability of the Quantra Viscoelastic Test in patients with hematologic malignancies and severe thrombocytopenia. The study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Thrombocytopenia

Snippet

Sponsor: Centre Hospitalier Annecy Genevois | Conditions: Hematologic Malignancies, Thrombopenia | NA | Status: COMPLETED